Gongdong Medical announced that on December 16, 2025, Shi Huiyong, the controlling shareholder and actual controller of the company, reduced its holdings by a total of 4,402,400 shares through bulk transactions, and the shareholding ratio fell from 50.27% to 48.27%; Taizhou Jinchi Investment Management Partnership reduced its holdings by 2,204,840 shares through centralized bidding, and the shareholding ratio fell from 6.47% to 5.47%. After this equity change, Shi Huiyong, Jinchi Investment and their co-actors reduced their total shareholding ratio of the company from 63.96% to 61.21%, and the equity change hit the 1% scale.

Gongdong Medical announced that on December 16, 2025, Shi Huiyong, the controlling shareholder and actual controller of the company, reduced its holdings by a total of 4,402,400 shares through bulk transactions, and the shareholding ratio fell from 50.27% to 48.27%; Taizhou Jinchi Investment Management Partnership reduced its holdings by 2,204,840 shares through centralized bidding, and the shareholding ratio fell from 6.47% to 5.47%. After this equity change, Shi Huiyong, Jinchi Investment and their co-actors reduced their total shareholding ratio of the company from 63.96% to 61.21%, and the equity change hit the 1% scale.